ARMC
AGN

American Research & Management Company’s Allergan plc AGN Stock Holding History

American Research & Management Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-33
Closed -$6K – 371
2020
Q1 		$6K Buy
+33
New +$6.21K ﹤0.01% 276
2015
Q2 		– Sell
-33
Closed -$10K – 401
2015
Q1 		$10K Hold
33
– – ﹤0.01% 283
2014
Q4 		$8K Hold
33
– – ﹤0.01% 296
2014
Q3 		$8K Buy
+33
New +$7.38K ﹤0.01% 300

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

American Research & Management Company's AGN Position: Q2 2020 in Review

American Research & Management Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 33 shares — an estimated $6K sold.

American Research & Management Company first reported a position in AGN in Q3 2014 and held it in 4 quarters. The position peaked at $10K in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • American Research & Management Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • American Research & Management Company sold 33 Allergan plc shares in Q2 2020, an estimated $6K.
  • American Research & Management Company first reported a position in Allergan plc in Q3 2014 and held it in 4 quarters.
  • American Research & Management Company's Allergan plc position peaked at $10K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on American Research & Management Company's 13F filing for Q2 2020, filed 28 Jul 2020.